Free Trial

Omega Healthcare Investors (NYSE:OHI) Stock Price Expected to Rise, Mizuho Analyst Says

Omega Healthcare Investors logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Mizuho raised its price target on Omega Healthcare Investors from $46 to $49, while maintaining a neutral rating; the target implied 4.2% upside from the prior close.
  • Analyst views are mixed: seven rate the stock Buy, seven Hold, and two Sell. The consensus price target is $50.93.
  • In its latest reported quarter, Omega’s EPS of $0.27 missed the $0.47 consensus estimate, while revenue of $340.55 million exceeded estimates but declined 3% year over year.
  • MarketBeat previews the top five stocks to own by December 1st.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) had its price target raised by Mizuho from $46.00 to $49.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has a "neutral" rating on the real estate investment trust's stock. Mizuho's price objective would suggest a potential upside of 4.20% from the company's previous close.

Several other research analysts have also recently commented on OHI. Barclays reduced their price target on Omega Healthcare Investors from $50.00 to $48.00 and set an "underweight" rating for the company in a research report on Tuesday, October 13th. Cantor Fitzgerald increased their target price on shares of Omega Healthcare Investors from $52.00 to $56.00 and gave the stock an "overweight" rating in a research report on Friday, July 31st. Raymond James Financial restated an "outperform" rating and issued a $54.00 target price on shares of Omega Healthcare Investors in a research report on Monday, November 9th. UBS Group upped their price objective on shares of Omega Healthcare Investors from $52.00 to $56.00 and gave the stock a "buy" rating in a research report on Wednesday, November 11th. Finally, Citizens Jmp upgraded shares of Omega Healthcare Investors from a "market perform" rating to a "market outperform" rating and set a $52.00 price objective for the company in a report on Thursday, October 22nd. Seven equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $50.93.

Get Our Latest Stock Report on Omega Healthcare Investors

Omega Healthcare Investors Trading Down 0.1%

Shares of OHI traded down $0.03 on Monday, reaching $47.02. 568,911 shares of the company's stock were exchanged, compared to its average volume of 2,073,414. Omega Healthcare Investors has a 12 month low of $42.18 and a 12 month high of $52.39. The business has a 50 day moving average price of $46.43 and a two-hundred day moving average price of $46.79. The stock has a market capitalization of $14.31 billion, a P/E ratio of 18.94, a price-to-earnings-growth ratio of 1.72 and a beta of 0.56.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The real estate investment trust reported $0.27 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.20). Omega Healthcare Investors had a net margin of 58.11% and a return on equity of 13.66%. The firm had revenue of $340.55 million during the quarter, compared to the consensus estimate of $269.16 million. Omega Healthcare Investors's quarterly revenue was down 3.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.79 EPS. Equities research analysts predict that Omega Healthcare Investors will post 3.12 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Utah Retirement Systems boosted its holdings in Omega Healthcare Investors by 0.7% during the 3rd quarter. Utah Retirement Systems now owns 45,651 shares of the real estate investment trust's stock worth $2,114,000 after acquiring an additional 313 shares during the last quarter. Strategic Global Advisors LLC lifted its position in shares of Omega Healthcare Investors by 273.1% during the 3rd quarter. Strategic Global Advisors LLC now owns 92,686 shares of the real estate investment trust's stock worth $4,292,000 after buying an additional 67,847 shares in the last quarter. Cetera Investment Advisers boosted its stake in shares of Omega Healthcare Investors by 9.6% in the 3rd quarter. Cetera Investment Advisers now owns 436,259 shares of the real estate investment trust's stock worth $20,203,000 after buying an additional 38,100 shares during the last quarter. Jump Financial LLC bought a new position in shares of Omega Healthcare Investors in the third quarter valued at approximately $2,070,000. Finally, EP Wealth Advisors LLC increased its position in shares of Omega Healthcare Investors by 31.2% during the third quarter. EP Wealth Advisors LLC now owns 20,932 shares of the real estate investment trust's stock valued at $969,000 after acquiring an additional 4,981 shares during the last quarter. Hedge funds and other institutional investors own 65.25% of the company's stock.

Omega Healthcare Investors Company Profile

(Get Free Report)

Omega Healthcare Investors, Inc. is a real estate investment trust (REIT) focused on healthcare facilities, particularly skilled nursing and assisted living properties. The company invests in these facilities through real estate leases, loans and other financing arrangements. Its portfolio serves healthcare operators in the United States and the United Kingdom. Omega primarily leases properties to third-party operators, which manage the facilities and provide care to residents. Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega is led by President and Chief Executive Officer Taylor Pickett.

Featured Stories

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Omega Healthcare Investors Right Now?

Before you consider Omega Healthcare Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.

While Omega Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines